Oddone Incisa
Analyst · Nicole DeBlase calling from Deutsche Bank
Thank you, Scott, and good morning, good afternoon to everyone on the call. Fourth quarter industrial net sales were down 5% year-over-year to $6 billion. The decline was mostly due to lower sales in agriculture equipment dealers, especially in South America. In Q4 of 2022, we have also seen a strong growth of dealer inventories in low horsepower tractors in North America, but those reduced significantly in the fourth quarter of 2023 as we underproduce retail by almost 40% in this product category during the second half of the year. For the full year, net sales were $2.1 billion, up 3% from 2022, mainly driven by price realization in the first half offsetting the lower unit sales in the full year. Our profits increased year-over-year in every single quarter despite a slow in sales. Adjusted net income was $2.3 billion for the year with an adjusted diluted EPS of $1.70, up $0.24 versus 2022. The negative impact from the Argentine peso devaluation and the resulting loss in value from our cash holdings was about $0.04 of both the adjusted and the unadjusted EPS. Q4 industrial free cash flow was $1.6 million. Full year free cash flow was $1.2 billion at the top of the most recent guidance range but down versus the previous year due to our effort to manage channel inventory. Industrial activities ended the year almost net debt-free. In agriculture, the net sales decrease of 8% in the quarter was driven by lower industry demand, especially in South America for all product categories and for combines in North America and EMEA. Full year net sales were up 1%, driven mainly by higher price utilization in North America, offset by the unfavorable volume and mix, mostly in South America. As we see cost reduction accelerating in our production system, we improved our gross margin in both the quarter and the full year, closing 2023 at 25.5%, up 170 basis points from 2022. Q4 EBIT and EBIT margin also benefited from [$14 million] of lower SG&A expenses. The full year adjusted EBIT increase of 1.4 percentage points was driven by favorable price over cost and higher JV income, which you'll find in the FX and other category, more than offsetting the adverse volume and mix in the second half of the year. Turning to construction. Net sales for Q4 were up 9% year-over-year, mostly due to price realization and higher volumes in North America, partially offset by lower volumes in EMEA and South America. Full year sales were up 10% to $3.9 billion, driven by the strength of North America demand and positive price realization. Gross margins increased by 2.3 percentage points in 2023 to 15.6% from favorable price over cost. Q4 adjusted EBIT also benefited from lower SG&A expenses, resulting in a 5.8% EBIT margin. The full year margin close to an all-time high of 6.1%, up to 160 basis points, substantially driven by the price of our product cost relationship. For Financial Services, net income in the fourth quarter was [$113 million], a 50% increase compared to Q4 2022. The sharp improvement was mostly driven by higher receivables portfolio across regions, better margins and lower risk costs, only partially offset by a higher effective tax rate for the segment. Retail originations in the quarter were $3.4 billion, up $0.5 billion compared to the same period of 2022 as we are capturing a higher percentage of our end customer equipment financing needs. The managed portfolio at year-end was nearly $29 billion, up over $5 billion compared to the prior year. We have been able to raise capital efficiently and affordably throughout the year to fund our credit operations. Financial Services profitability ratios have also improved year-over-year, and delinquencies remain at a very low level, even slightly higher than in 2022. This reflects the solid nature of agriculture equipment financing. Moving to our capital allocation priorities. At the 2022 Capital Market Day, we announced a $4.4 billion combined R&D and CapEx spending over '22 to 2024. Almost double what we spent in ag construction in the previous three years, as we were no longer required to fund the on-highway capital needs of the larger CNH industrial. In the first two years of the plan, we spent $3 billion, reflecting increased activity levels and some inflation. We remain committed to invest in our business to fuel our profitable growth and we'll spend around $1.4 billion to $1.5 billion in 2024 between R&D and CapEx. We are confident the products, technology and services that we're bringing to the market by virtue of the spending will ensure a better financial performance for the company and more importantly, higher productivity for our customers. Our solid cash generation and healthy balance sheet are helping us improve our investment-grade credit rating. And last November, as S&P raised by one notch our rating to BBB+ with stable outlook. In 2023, we returned about $1.2 billion to shareholders through dividends and share repurchases. As you know, in November, we launched a $1 billion share buyback program in conjunction with our move to a single listing in New York with a target completion by March 1. To date, we have purchased about $935 million worth of shares between Milan and New York. And so we will likely complete the current program by the end of this month. The Board has authorized a new $500 million program share repurchase program that we will start at the end of this year. We also expect that the dividend distribution, consistent with our dividend policies and reflective of the higher net income achieved in 2023 will be approved by our shareholder meeting. Finally, we will continue to seek opportunities to improve our product offerings and advance our tax to M&A, including through our CNH [indiscernible]. Before turning back to Scott with a broader industry and company outlook, I would like to provide you with some details regarding our 2024 financial assumptions. Net price realization is expected to be between flat and 2% depending on the product and in the region. On average, for all products and regions, pricing will be around 1%. Again, we expect to spend between $1.4 billion and $1.5 billion on combined R&D and CapEx in 2024, with R&D expenses about flat year-over-year at around $1 billion and CapEx between $400 million and $500 million. Corporate expenses or what we call unallocated and other industrial activities are expected to be about flat year-over-year in absolute dollar terms. At the company level, the adjusted effective tax rate would be in the range of 25% to 27%, similar to 2023. The diluted share count is estimated t about $1.25 billion, factoring in the impact of our current buyback program. I will now turn it back to Scott.